首页> 外国专利> Discovery of regulatory T cells programmed to suppress an immune response

Discovery of regulatory T cells programmed to suppress an immune response

机译:发现被调节为抑制免疫反应的调节性T细胞

摘要

A method to treat an autoimmune disease is provided. The method involves administration of interleukin-15 receptor (IL-15R) agonists in an amount effective to ameliorate a symptom of the autoimmune disease. The invention also involves a method to treat an autoimmune disease by ex- vivo expansion of CD44+CD122+Kir+ CD8+ Treg cells and administration of the CD44+CD122+Kir+ CD8+ Treg cells. Compositions comprising CD44+CD122+Kir+ CD8+ Treg cells are also provided. Methods for stimulating an immune response to an antigen are also provided.
机译:提供了一种治疗自身免疫疾病的方法。该方法包括以有效改善自身免疫疾病症状的量施用白介素-15受体(IL-15R)激动剂。本发明还涉及通过体外扩增CD44 + CD122 + Kir + CD8 + Treg细胞并施用CD44 + CD122 + Kir + CD8 + Treg细胞来治疗自身免疫疾病的方法。还提供了包含CD44 + CD122 + Kir + CD8 + Treg细胞的组合物。还提供了刺激对抗原的免疫应答的方法。

著录项

  • 公开/公告号AU2011317211A1

    专利类型

  • 公开/公告日2013-05-02

    原文格式PDF

  • 申请/专利权人 DANA-FARBER CANCER INSTITUTE INC.;

    申请/专利号AU2011317211A1

  • 发明设计人 CANTOR HARVEY;KIM HYE-JUNG;LU LINRONG;

    申请日2011-10-18

  • 分类号C07K14/54;A01H5;A01H5/08;A01H5/12;A23L1/212;A23L1/216;A61K38/20;C12N5/10;C12N15/63;H04N5/93;

  • 国家 AU

  • 入库时间 2022-08-21 16:37:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号